RosTrace

Tag: Biotech Innovation

Robin Hayes

ADC189: A Promising Single-Dose Oral Therapy for Influenza Emerges from Preclinical and Phase I Trials

Seasonal influenza continues to exact a heavy toll on global health, causing an estimated 3–5 million cases of severe illness and up to 650,000 respiratory deaths annually. Existing antivirals—principally neuraminidase inhibitors (such as oseltamivir) and M2 ion-channel blockers (amantadine and rimantadine)—have demonstrable limitations. Resistance to these agents has steadily increased, and their efficacy is often modest when administered more than 48 hours after symptom onset. Moreover, the logistical challenges of multi-dose regimens hinder public health efforts during epidemics and pandemics. There is therefore an urgent need for a novel, broadly active, single-dose antiviral that can both treat and prevent influenza, including resistant and pandemic strains.

· 4 min read

Sage Bennett

AI Breakthrough Promises to Revolutionise Protein Engineering and Accelerate Drug Discovery

In a landmark study published in Nature Machine Intelligence, researchers from the University of Sheffield, AstraZeneca, and the University of Southampton unveiled an artificial intelligence framework—MapDiff—that dramatically improves inverse protein folding predictions. By steering amino acid sequence generation toward desired three-dimensional structures, MapDiff represents a major advance in protein engineering, with the potential to transform the development of new vaccines, gene therapies, and other biologics. This article explores the scientific challenge of inverse folding, details the new machine learning approach, and examines the implications for drug innovation.

· 5 min read